Literature DB >> 22240939

Interstitial brachytherapy using virtual planning and Doppler transrectal ultrasonography guidance for internal iliac lymph node metastasis.

Ken Yoshida1, Mari Ueda, Hideya Yamazaki, Tadashi Takenaka, Mineo Yoshida, Shunsuke Miyake, Susumu Yoshida, Masahiko Koizumi, Chiaki Ban, Eiichi Tanaka.   

Abstract

To expand the indications for high-dose-rate interstitial brachytherapy (HDR-ISBT) for deep-seated pelvic tumors, we investigated the usefulness of Doppler transrectal ultrasonography (TRUS) guidance and virtual planning. The patient was a 36-year-old female. She had right internal iliac lymph node oligometastasis of vaginal cancer 12 months after radical radiotherapy. The tumor could not be found by gray-scale TRUS and physical examination. Virtual planning was performed using computed tomography with template and vaginal cylinder insertion. We uploaded the images to our treatment planning software and reconstructed the contours of the clinical target volume (CTV) and right internal iliac vessel. Virtual needle applicators were plotted using the template holes for virtual planning. At the time of implantation, Doppler TRUS was used to prevent vessel injury by needle applicators. Applicators were implanted in accordance with virtual planning and Doppler TRUS could detect the right iliac vessel. The percentage of CTV covered by the prescribed dose was 99.8%. The minimum dose received by the maximally irradiated 0.1-cc volume for the right internal iliac vessel was 95% prescribed dose. Complete response was achieved, however, radiological findings showed marginal recurrence at 15 months after HDR-ISBT. Post-radiation neuropathy occurred as a late complication four months after treatment; however, the pain was well controlled by medication. We consider that virtual planning and Doppler TRUS are effective methods in cases where it is difficult to detect the tumor by physical examination and gray-scale TRUS, thereby expanding the indications for ISBT.

Entities:  

Mesh:

Year:  2012        PMID: 22240939     DOI: 10.1269/jrr.11142

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  4 in total

1.  Strength estimation of a moving 125Iodine source during implantation in brachytherapy: application to linked sources.

Authors:  Kenichi Tanaka; Satoru Endo; Kunihiko Tateoka; Osamu Asanuma; Masakazu Hori; Masaru Takagi; Gerard Bengua; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masato Hareyama; Koh-Ichi Sakata; Jun Takada
Journal:  J Radiat Res       Date:  2014-07-01       Impact factor: 2.724

2.  CT-Guided Pelvic Lymph Nodal Brachytherapy.

Authors:  Hiroaki Kunogi; I-Chow Hsu; Nanae Yamaguchi; Soshi Kusunoki; Keiko Nakagawa; Yayoi Sugimori; Kazunari Fujino; Yasuhisa Terao; Daiki Ogishima; Ryoichi Yoshimura; Keisuke Sasai
Journal:  Front Oncol       Date:  2021-02-19       Impact factor: 6.244

3.  High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.

Authors:  Yuri Shimizu; Naoya Murakami; Takahito Chiba; Tomoya Kaneda; Hiroyuki Okamoto; Satoshi Nakamura; Ayaka Takahashi; Tairo Kashihara; Kana Takahashi; Koji Inaba; Kae Okuma; Yuko Nakayama; Jun Itami; Hiroshi Igaki
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

4.  Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy.

Authors:  Kenichi Tanaka; Satoru Endo; Kunihiko Tateoka; Osamu Asanuma; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masaru Takagi; Masato Hareyama; Jun Takada
Journal:  J Radiat Res       Date:  2013-06-30       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.